Ms Andrea Reid > Dechert LLP > Boston, United States > Lawyer Profile

Regarded by some clients as ‘easily the best’, Dechert LLP’s global life sciences practice often handles patent and IP litigations, contentious antitrust matters, and product liability related issues. Working with a host of start-ups and mature pharmaceutical and biotech companies, Andrea Reid co-heads the team from Boston, drawing on her expertise in IP strategy and prosecution. Based in New York, the ‘truly exceptional‘ fellow co-chair David S Rosenthal maintains a corporate finance and life sciences M&A focused practice. Rosenthal routinely advises public and private investment banks and venture capital firms on IPOs and CMPOs looking to invest in life sciences and medical device companies. Also based in New York, Katherine Helm notably acts for biotech and pharmaceutical companies in biologics patent disputes before the PTAB.

Dechert LLP‘s Boston-based practice is co-led by Andrea Reid and Andrew Wilkins, who is described as ‘one of the best IP counsel’. The team is adept at advising on prosecution in a multitude of areas, though there is an evident expertise across the board in biotech, with the team being noted as a ‘terrific partner when it comes to new technologies’. Additionally, its work in life sciences and pharmaceuticals is noteworthy, a key example being Reid and the ‘business-centric’ and ‘excellent’ Chad Davis representing AVEO Oncology on the $566m multi-jurisdictional creation of its patent portfolio following its acquisition by LG Chem. Scott Warren  left the firm in August 2022.